Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia

John P. Breinholt, Brady S. Moffett, Karen M. Texter, Frank Ing

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening, adverse effect of heparin therapy. Patients with this complication require an alternative approach to anticoagulation. Bivalirudin is a direct thrombin inhibitor with an efficacy comparable to that of heparin, a short half-life, and reduced bleeding complications in adults. We present the case of a 2-year-old boy with HIT Type II who underwent recanalization of an occluded superior vena cava and stent placement, utilizing bivalirudin as anticoagulant.

Original languageEnglish (US)
Pages (from-to)804-807
Number of pages4
JournalPediatric Cardiology
Volume29
Issue number4
DOIs
StatePublished - Jul 1 2008
Externally publishedYes

Fingerprint

Superior Vena Cava
Thrombocytopenia
Stents
Heparin
Antithrombins
Anticoagulants
Half-Life
Hemorrhage
bivalirudin
Therapeutics

Keywords

  • Anticoagulation
  • Congenital heart disease
  • Thrombosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this

Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia. / Breinholt, John P.; Moffett, Brady S.; Texter, Karen M.; Ing, Frank.

In: Pediatric Cardiology, Vol. 29, No. 4, 01.07.2008, p. 804-807.

Research output: Contribution to journalArticle

@article{a4971988feeb4048890c566a1a29d7fb,
title = "Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia",
abstract = "Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening, adverse effect of heparin therapy. Patients with this complication require an alternative approach to anticoagulation. Bivalirudin is a direct thrombin inhibitor with an efficacy comparable to that of heparin, a short half-life, and reduced bleeding complications in adults. We present the case of a 2-year-old boy with HIT Type II who underwent recanalization of an occluded superior vena cava and stent placement, utilizing bivalirudin as anticoagulant.",
keywords = "Anticoagulation, Congenital heart disease, Thrombosis",
author = "Breinholt, {John P.} and Moffett, {Brady S.} and Texter, {Karen M.} and Frank Ing",
year = "2008",
month = "7",
day = "1",
doi = "10.1007/s00246-008-9231-2",
language = "English (US)",
volume = "29",
pages = "804--807",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia

AU - Breinholt, John P.

AU - Moffett, Brady S.

AU - Texter, Karen M.

AU - Ing, Frank

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening, adverse effect of heparin therapy. Patients with this complication require an alternative approach to anticoagulation. Bivalirudin is a direct thrombin inhibitor with an efficacy comparable to that of heparin, a short half-life, and reduced bleeding complications in adults. We present the case of a 2-year-old boy with HIT Type II who underwent recanalization of an occluded superior vena cava and stent placement, utilizing bivalirudin as anticoagulant.

AB - Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening, adverse effect of heparin therapy. Patients with this complication require an alternative approach to anticoagulation. Bivalirudin is a direct thrombin inhibitor with an efficacy comparable to that of heparin, a short half-life, and reduced bleeding complications in adults. We present the case of a 2-year-old boy with HIT Type II who underwent recanalization of an occluded superior vena cava and stent placement, utilizing bivalirudin as anticoagulant.

KW - Anticoagulation

KW - Congenital heart disease

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=46749104466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749104466&partnerID=8YFLogxK

U2 - 10.1007/s00246-008-9231-2

DO - 10.1007/s00246-008-9231-2

M3 - Article

C2 - 18414931

AN - SCOPUS:46749104466

VL - 29

SP - 804

EP - 807

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 4

ER -